Michael Gelband’s AMN Healthcare AMN Stock Holding History

Michael Gelband’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,757	Closed	-$963K	–	1507
2025 Q3	$963K	Buy	+49,757	New	+$972K	0.01%	973
2025 Q2	–	Sell	-70,682	Closed	-$1.73M	–	1434
2025 Q1	$1.73M	Buy	+70,682	New	+$1.82M	0.02%	744
2024 Q4	–	Sell	-70,394	Closed	-$2.98M	–	1482
2024 Q3	$2.98M	Buy	+70,394	New	+$3.69M	0.02%	587
2024 Q1	–	Sell	-27,064	Closed	-$2.03M	–	1462
2023 Q4	$2.03M	Buy	+27,064	New	+$1.94M	0.01%	570
2023 Q3	–	Sell	-20,304	Closed	-$2.22M	–	1667
2023 Q2	$2.22M	Sell	20,304 -28,173	-58%	-$2.67M	0.02%	769
2023 Q1	$4.02M	Buy	48,477 +41,166	+563%	+$3.88M	0.03%	589
2022 Q4	$752K	Sell	7,311 -26,220	-78%	-$3.02M	0.01%	1045
2022 Q3	$3.55M	Buy	+33,531	New	+$3.68M	0.05%	527
2022 Q1	–	Sell	-12,501	Closed	-$1.53M	–	2157
2021 Q4	$1.53M	Buy	+12,501	New	+$1.39M	0.02%	868
2021 Q2	–	Sell	-22,443	Closed	-$1.65M	–	2298
2021 Q1	$1.65M	Buy	+22,443	New	+$1.67M	0.02%	645
2020 Q3	–	Sell	-6,454	Closed	-$292K	–	1713
2020 Q2	$292K	Buy	+6,454	New	+$309K	0.01%	1328
2019 Q3	–	Sell	-7,900	Closed	-$429K	–	1310
2019 Q2	$429K	Buy	+7,900	New	+$401K	0.02%	537

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's AMN Position: Q4 2025 in Review

Michael Gelband sold out of AMN Healthcare (AMN) in Q4 2025, closing a stake of 49,757 shares — an estimated $963K sold.

Michael Gelband first reported a position in AMN in Q2 2019 and held it in 12 quarters. The position peaked at $4.02M in Q1 2023. 236 funds tracked by Wall St. Rank hold AMN as of Q4 2025.

Michael Gelband reported no remaining AMN Healthcare position as of Q4 2025 after selling out during the quarter.
Michael Gelband sold 49,757 AMN Healthcare shares in Q4 2025, an estimated $963K.
Michael Gelband first reported a position in AMN Healthcare in Q2 2019 and held it in 12 quarters.
Michael Gelband's AMN Healthcare position peaked at $4.02M in Q1 2023.
236 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.